These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 3949973

  • 1. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B, Sniderman AD, Soutar AK, Thompson GR.
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [Abstract] [Full Text] [Related]

  • 2. VLDL and IDL apolipoprotein B-100 kinetics in familial hypercholesterolemia due to impaired LDL receptor function or to defective apolipoprotein B-100.
    Zulewski H, Ninnis R, Miserez AR, Baumstark MW, Keller U.
    J Lipid Res; 1998 Feb; 39(2):380-7. PubMed ID: 9507998
    [Abstract] [Full Text] [Related]

  • 3. Influence of obesity on the metabolism of apolipoprotein B in humans.
    Egusa G, Beltz WF, Grundy SM, Howard BV.
    J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
    [Abstract] [Full Text] [Related]

  • 4. Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9.
    Ouguerram K, Chetiveaux M, Zair Y, Costet P, Abifadel M, Varret M, Boileau C, Magot T, Krempf M.
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1448-53. PubMed ID: 15166014
    [Abstract] [Full Text] [Related]

  • 5. Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study.
    Cummings MH, Watts GF, Umpleby M, Hennessy TR, Quiney JR, Sönksen PH.
    Atherosclerosis; 1995 Feb; 113(1):79-89. PubMed ID: 7755658
    [Abstract] [Full Text] [Related]

  • 6. Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.
    Tremblay AJ, Lamarche B, Ruel IL, Hogue JC, Deshaies Y, Gagné C, Couture P.
    Atherosclerosis; 2006 Sep; 188(1):203-12. PubMed ID: 16337207
    [Abstract] [Full Text] [Related]

  • 7. ApoB metabolism in familial hypercholesterolemia. Inconsistencies with the LDL receptor paradigm.
    Fisher WR, Zech LA, Stacpoole PW.
    Arterioscler Thromb; 1994 Apr; 14(4):501-10. PubMed ID: 8148348
    [Abstract] [Full Text] [Related]

  • 8. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN, Le NA, Gibson JC.
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [Abstract] [Full Text] [Related]

  • 9. Direct synthesis of low-density lipoprotein apoprotein B in the miniature pig.
    Huff MW, Telford DE.
    Metabolism; 1985 Jan; 34(1):36-42. PubMed ID: 3965861
    [Abstract] [Full Text] [Related]

  • 10. Abnormalities in metabolism of low density lipoproteins associated with coronary heart disease.
    Grundy SM, Vega GL, Kesäniemi YA.
    Acta Med Scand Suppl; 1985 Jan; 701():23-37. PubMed ID: 3907293
    [Abstract] [Full Text] [Related]

  • 11. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
    Ginsberg HN, Le NA, Goldberg IJ, Gibson JC, Rubinstein A, Wang-Iverson P, Norum R, Brown WV.
    J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
    [Abstract] [Full Text] [Related]

  • 12. Lipoprotein metabolism in familial hypercholesterolemia.
    Shepherd J, Packard CJ.
    Arteriosclerosis; 1989 Nov; 9(1 Suppl):I39-42. PubMed ID: 2912431
    [Abstract] [Full Text] [Related]

  • 13. Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.
    Taskinen MR, Packard CJ, Shepherd J.
    Diabetes; 1990 Sep; 39(9):1017-27. PubMed ID: 2200727
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions.
    Packard CJ, Demant T, Stewart JP, Bedford D, Caslake MJ, Schwertfeger G, Bedynek A, Shepherd J, Seidel D.
    J Lipid Res; 2000 Feb; 41(2):305-18. PubMed ID: 10681415
    [Abstract] [Full Text] [Related]

  • 15. Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes.
    Ouguerram K, Magot T, Zaïr Y, Marchini JS, Charbonnel B, Laouenan H, Krempf M.
    J Pharmacol Exp Ther; 2003 Jul; 306(1):332-7. PubMed ID: 12684543
    [Abstract] [Full Text] [Related]

  • 16. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein.
    Huff MW, Telford DE.
    Arteriosclerosis; 1989 Jul; 9(1):58-66. PubMed ID: 2912422
    [Abstract] [Full Text] [Related]

  • 17. Metabolic pathways of apolipoprotein B in heterozygous familial hypercholesterolemia: studies with a [3H]leucine tracer.
    Fisher WR, Zech LA, Kilgore LL, Stacpoole PW.
    J Lipid Res; 1991 Nov; 32(11):1823-36. PubMed ID: 1770302
    [Abstract] [Full Text] [Related]

  • 18. Quantitative studies of very low density lipoprotein: conversion to low density lipoprotein in normal controls and primary hyperlipidaemic states and the role of direct secretion of low density lipoprotein in heterozygous familial hypercholesterolaemia.
    Janus ED, Nicoll A, Wootton R, Turner PR, Magill PJ, Lewis B.
    Eur J Clin Invest; 1980 Apr; 10(2 Pt 1):149-59. PubMed ID: 6780363
    [Abstract] [Full Text] [Related]

  • 19. Low-density lipoprotein receptor binding determinants switch from apolipoprotein E to apolipoprotein B during conversion of hypertriglyceridemic very-low-density lipoprotein to low-density lipoproteins.
    Bradley WA, Hwang SL, Karlin JB, Lin AH, Prasad SC, Gotto AM, Gianturco SH.
    J Biol Chem; 1984 Dec 10; 259(23):14728-35. PubMed ID: 6501314
    [Abstract] [Full Text] [Related]

  • 20. Influence of atorvastatin and simvastatin on apolipoprotein B metabolism in moderate combined hyperlipidemic subjects with low VLDL and LDL fractional clearance rates.
    Forster LF, Stewart G, Bedford D, Stewart JP, Rogers E, Shepherd J, Packard CJ, Caslake MJ.
    Atherosclerosis; 2002 Sep 10; 164(1):129-45. PubMed ID: 12119202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.